| Sanofi-Aventis (Suisse) SA - Efluelda 0.7 ml, suspension injectable en seringue préremplie | | 67704 | | 01 | | Efluelda 0.7 ml | | suspension injectable en seringue préremplie | | J07BB02 | | Influenza, gereinigtes Antigen | | 21.07.2021 | | |
| | Zusammensetzung | | haemagglutininum influenzae A (H1N1) (Virus souche A/Michigan/45/2015 (H1N1)-like: reassortant virus NYMC X-275 derived from A/Michigan/45/2015) 60 µg, haemagglutininum influenzae A (H3N2) (Virus souche A/Singapore/INFIMH-16-0019/2016 (H3N2)-like: reassortant virus IVR-186 derived from A/Singapore/INFIMH-16-0019/2016 ) 60 µg, haemagglutininum influenzae B (Virus souche B/Phuket/3073/2013 (Yamagata lineage) (wild type)) 60 µg, haemagglutininum influenzae B (Virus souche B/Colorado/06/2017-like: reassortant virus NYMC BX-69A derived from B/Maryland/15/2016 (Victoria lineage)) 60 µg, natrii chloridum, dinatrii phosphas, natrii dihydrogenophosphas anhydricus, octoxinolum-9, aqua ad iniectabile q.s. ad suspensionem pro 0.7 ml corresp. natrium 2.72 mg. | | Packungsbestandteile | | | | | | | | Wirkstoffe | Stärke |
|---|
| | 60µg / 0.7ml | | | 60µg / 0.7ml | | | 60µg / 0.7ml |
| | | | Hilfsstoffe | Stärke |
|---|
| Dinatrii Phosphas | | | | 60µg / 0.7ml | | Natrii Chloridum | | | Natrii Dihydrogenophosphas Anhydricus | | | | |
|
| | Packungsnummer | Packungsgrösse | EFP | PP | Kat. | SL | In Refdata nicht gelistet |
|---|
| Es wurden keine Einträge gefunden. |
|
|
